Shawn McCormick Insider Trading $NVRO NEVRO CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shawn McCormick.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shawn McCormick. Shawn McCormick is Director in SURMODICS INC ($SRDX) and Sr. VP and CFO in ev3 Inc. ($EVVV) and Director in ENTELLUS MEDICAL INC ($ENTL) and Director in NEVRO CORP ($NVRO) and Chief Financial Officer in Wright Medical Group N.V. ($TRNX) and Director in Inspire Medical Systems, Inc. ($INSP).
Shawn McCormick in NEVRO CORP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Shawn McCormick: Director
Holdings: 7,290 shares
Current Value: $680,376
Latest Transaction: May 26 2021
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Shawn McCormick in NEVRO CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ENTL, EVVV, INSP, NVRO, SRDX, TRNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2021 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 1,167 | 0 | 8,457 | 7.3 K to 8.5 K (+16.01 %) |
| May 26 2021 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 149.65 | 482 | 72,131 | 7,290 | 7.8 K to 7.3 K (-6.20 %) |
| May 26 2020 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 126.50 | 1,020 | 129,030 | 7,772 | 8.8 K to 7.8 K (-11.60 %) |
| May 26 2020 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 1,376 | 0 | 8,792 | 7.4 K to 8.8 K (+18.55 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 104.35 | 800 | 83,480 | 7,416 | 8.2 K to 7.4 K (-9.74 %) |
| Nov 13 2019 | NVRO | NEVRO CORP | McCormick Shawn | Director | Sell | S | 104.35 | 800 | 83,480 | 7,416 | 8.2 K to 7.4 K (-9.74 %) |
| May 22 2019 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 2,913 | 0 | 8,216 | 5.3 K to 8.2 K (+54.93 %) |
| May 23 2018 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 3,785 | 0 | 5,303 | 1.5 K to 5.3 K (+249.34 %) |
| May 30 2017 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 74.07 | 3,545 | 262,578 | 3,545 | |
| May 30 2017 | NVRO | NEVRO CORP | McCormick Shawn | Director | Grant | A | 0.00 | 1,518 | 0 | 1,518 | 0 to 1.5 K |
| May 20 2016 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 63.39 | 3,240 | 205,384 | 3,240 | |
| Jun 01 2015 | NVRO | NEVRO CORP | McCormick Shawn | Director | Option Exercise | A | 50.50 | 4,182 | 211,191 | 4,182 |
Page: 1